Davis, Kyle W.
Bilancia, Colleen G.
Martin, Megan
Vanzo, Rena
Rimmasch, Megan
Hom, Yolanda
Uddin, Mohammed
Serrano, Moises A.
Funding for this research was provided by:
Bionano Genomics, Inc.
Article History
Received: 6 April 2021
Accepted: 8 March 2022
First Online: 31 March 2022
Competing interests
: Megan Martin, Rena Vanzo, Dr. Colleen G. Bilancia, and Dr. Moises Serrano all are employees of and hold stock options in Bionano Genomics, Inc. Kyle W. Davis and Megan Rimmasch were previously employed by Bionano Genomics, Inc. and Kyle W. Davis own stock options in Bionano Genomics, Inc. Dr. Mohammed Uddin is listed as an inventor on a patent application for his work on critical exon indexing (upon which the Index gene metric is based); the patent is held by Toronto Hospital for Sick Children and licensed by Lineagen Inc, a Bionano Genomics Company. Yolanda Hom has declared no competing interests.